Neogen Corp
NEOGNasdaqCIK 711377HealthcareFiscal year ends May 31
Reports and events: 280 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2609:16 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-431208 |
| 2026-10-0716:02 ET | 10-Q | Quarterly reportPeriod 2026-08-31 | 0001193125-26-416954 |
| 2026-10-0708:55 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-416247 |
| 2026-10-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-415544 |
| 2026-08-2114:02 ET | DEF 14A | Proxy statementPeriod 2026-08-21 | 0001193125-26-360742 |
| 2026-08-0716:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-340216 |
| 2026-07-3016:04 ET | 10-K | Annual reportPeriod 2026-05-31 | 0001193125-26-326092 |
| 2026-07-3007:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-324860 |
| 2026-04-2006:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-162667 |
| 2026-04-0916:03 ET | 10-Q | Quarterly reportPeriod 2026-02-28 | 0001193125-26-149599 |
| 2026-04-0907:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-148851 |
| 2026-03-3008:19 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-130470 |
| 2026-01-0816:07 ET | 10-Q | Quarterly reportPeriod 2025-11-30 | 0001193125-26-007682 |
| 2026-01-0807:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-006990 |
| 2025-10-3008:47 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-257565 |
| 2025-10-2811:28 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-252843 |
| 2025-10-2710:55 ET | 8-K/A | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-250963 |
| 2025-10-2709:08 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-250823 |
| 2025-10-0915:04 ET | 10-Q | Quarterly reportPeriod 2025-08-31 | 0001193125-25-235720 |
| 2025-10-0907:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-235081 |
| 2025-09-1516:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-203554 |
| 2025-09-1209:32 ET | DEF 14A | Proxy statementPeriod 2025-09-12 | 0000950170-25-114381 |
| 2025-08-2106:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-110547 |
| 2025-08-1416:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-108900 |
| 2025-07-3013:33 ET | 10-K | Annual reportPeriod 2025-05-31 | 0000950170-25-100064 |
| 2025-07-2907:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-099379 |
| 2025-07-2409:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-098159 |
| 2025-06-0408:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-081407 |
| 2025-05-1413:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-071169 |
| 2025-05-1316:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-070353 |
| 2025-04-2216:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-056821 |
| 2025-04-0916:04 ET | 10-Q | Quarterly reportPeriod 2025-02-28 | 0000950170-25-052497 |
| 2025-04-0907:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-052304 |
| 2025-04-0907:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-052302 |
| 2025-04-0712:36 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-051441 |
| 2025-01-1515:53 ET | 10-Q | Quarterly reportPeriod 2024-11-30 | 0000950170-25-005818 |
| 2025-01-1007:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-003775 |
| 2025-01-0716:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-002820 |
| 2024-12-1716:01 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-137170 |
| 2024-12-0407:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-133084 |
| 2024-10-2815:59 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-117710 |
| 2024-10-1014:14 ET | 10-Q | Quarterly reportPeriod 2024-08-31 | 0000950170-24-114022 |
| 2024-10-1007:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-113951 |
| 2024-10-1006:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-113950 |
| 2024-10-0108:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-110564 |
| 2024-09-1309:26 ET | DEF 14A | Proxy statementPeriod 2024-10-24 | 0000950170-24-106219 |
| 2024-09-0507:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-103737 |
| 2024-07-3013:58 ET | 10-K | Annual reportPeriod 2024-05-31 | 0000950170-24-087670 |
| 2024-07-3006:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-087499 |
| 2024-06-0408:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-068311 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 15:36 ET. Listed shows no prices and gives no investment advice.